Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer
Clinical trial NCT06356155 · RECRUITING
Trial details
- NCT number
- NCT06356155
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-22
- Primary completion
- 2028-03-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.